@TLRailUK@KayaBieRas If I have an off-peak return ticket I wanted to use today can I use it tomorrow morning instead to get down to Brighton? Will the line be open by then? Or is the only option to go via Hastings? Are there no rail replacement coaches being arranged to get people down to Gatwick?
With universities unable to afford them, clinical academics across the country are being offered redundancy.
These are the people who teach our doctors and conduct ground breaking research.
More must be done to support them.
🫁 SBRT has forever changed lung cancer treatment. With sub-millimeter accuracy, we now treat and even cure lung cancer in a single session. There is zero downtime with this treatment as there’s no need for anesthesia or even lidocaine. It’s just amazing. #radonc https://t.co/VSWqrv3dDX
Tony Blair recounts a ridiculous tie design procurement process for an EU summit (featuring an Italian accent).
Not sure any frontline UK politician today could carry a story like that.
Thirty years ago, the late great 🇬🇧 statistician Douglas Altman wrote what would go on to become one of the most highly cited editorials in medicine: "The scandal of poor medical research"
If he were alive today, I suspect he'd feel things are even worse
https://t.co/oQRXq9WNU6
📢 Super excited to share our new study @NatureMedicine on developing and validating an explainable graph-based foundation model for drug repurposing, designed specially for rare diseases, which collectively affect 300 million patients globally!
🧵1/10
Learning about the process of ferroptosis. Any potential to link to iron oxide for selective targeting? Above my knowledge level, but it makes me curious 🤔 #radbio#ASTRO24
Recent Data of #Theranostics published in the @TheLancet: LuPSMA therapy can improve PFS of patients with metastatic prostate cancer before trying chemotherapy or also as a booster to chemotherapy. Kudos to the trialists!
https://t.co/RScbQkRPeY
https://t.co/GsWSXBo3Zg
My sister in law just reminded me of the event that helped turn me from internal medicine to anaesthesia.
Being on scene without the skills or equipment, with more and more critically injured people being brought out remains with me for ever.
Bispecific antibodies (bsAbs) allow therapeutic applications that cannot be achieved using conventional antibodies. There are 14 bsAbs approved: 11 for cancer & 3 for non-oncology indications. This review summarizes this very active field, including bsAb signaling pathway modulators, tumor-targeted receptor agonists, ADC, bispecific T cell, natural killer cell & checkpoint inhibitors.https://t.co/L4qdRTL5Cr
Online Now: Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells https://t.co/c7UE3PwKzA
Check out our latest study on the DNA polymerase theta (Polθ), a precision oncology target for HDR-deficient cancers. Our work uncovers the inhibitory mechanism of a potent Polθ inhibitor using cryoEM, accelerating rational drug development strategies:
https://t.co/ctvAprYhAI
Just saw this permanent iodine brachytherapy paper for inoperable pancreas ca and it's really amazing. 20x20 template implant into the pancreas using lidocaine & breath hold. The liver and bowel could be penetrated during seed implantation if necessary. PMID: 35494180 #radonc
Happy to share a publication from the lab demonstrating that 53BP1 loss is a positive predictive biomarker for immune checkpoint blockade efficacy, with important implications for the treatment of PARPi-resistant ovarian and pancreatic cancers!
https://t.co/a09GX4ipAi